{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T08:44:45Z","timestamp":1790844285115,"version":"4.1.0"},"reference-count":111,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T00:00:00Z","timestamp":1714608000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["European J of Haematology"],"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Chronic lymphocytic leukemia (CLL) is a mature\u2010type B cell malignancy correlated with significant changes and defects in both the innate and adaptive arms of the immune system, together with a high dependency on the tumor microenvironment. Overall, the tumor microenvironment (TME) in CLL provides a supportive niche for leukemic cells to grow and survive, and interactions between CLL cells and the TME can contribute to disease progression and treatment resistance. Therefore, the increasing knowledge of the complicated interaction between immune cells and tumor cells, which is responsible for immune evasion and cancer progression, has provided an opportunity for the development of new therapeutic approaches. In this review, we outline tumor microenvironment\u2010driven contributions to the licensing of immune escape mechanisms in CLL patients.<\/jats:p>","DOI":"10.1111\/ejh.14224","type":"journal-article","created":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T06:20:40Z","timestamp":1714717240000},"page":"4-15","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Cross\u2010talk between leukemic and immune cells at the tumor microenvironment in chronic lymphocytic leukemia: An update review"],"prefix":"10.1111","volume":"113","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8813-6046","authenticated-orcid":false,"given":"Saeid","family":"Taghiloo","sequence":"first","affiliation":[{"name":"Department of Immunology, School of Medicine Mazandaran University of Medical Sciences  Sari Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3816-8792","authenticated-orcid":false,"given":"Hossein","family":"Asgarian\u2010Omran","sequence":"additional","affiliation":[{"name":"Department of Immunology, School of Medicine Mazandaran University of Medical Sciences  Sari Iran"},{"name":"Gastrointestinal Cancer Research Center, School of Medicine Mazandaran University of Medical Sciences  Sari Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2024,5,2]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2015.11.003"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2014.05.006"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2016.06.003"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2015.03.047"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21051825"},{"issue":"5","key":"e_1_2_9_7_1","first-page":"573","article-title":"Perturbation of the normal immune system in patients with CLL","volume":"126","author":"Forconi F","year":"2015","journal-title":"Blood J Am Soc Hematol"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2020.268037"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-023-01426-w"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.2008.02030.x"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.2174\/138161212801227041"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.2119\/2008-00102.Catera"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxu001"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-09-3535"},{"issue":"9","key":"e_1_2_9_15_1","first-page":"4723","article-title":"IL\u201021 mediates apoptosis through up\u2010regulation of the BH3 family member BIM and enhances both direct and antibody\u2010dependent cellular cytotoxicity in primary chronic lymphocytic leukemia cells in vitro","volume":"111","author":"Gowda A","year":"2008","journal-title":"Blood J Am Soc Hematol"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.594556"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021006941"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2013.05.021"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2016.151100"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02720"},{"issue":"20","key":"e_1_2_9_21_1","first-page":"4441","article-title":"Diverse marrow stromal cells protect CLL cells from spontaneous and drug\u2010induced apoptosis: development of a reliable and reproducible system to assess stromal cell adhesion\u2010mediated drug resistance","volume":"114","author":"Kurtova AV","year":"2009","journal-title":"Blood J Am Soc Hematol"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2009.07868.x"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1089\/scd.2012.0255"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13286"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.01422"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2011.02.027"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1102066"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2011.054924"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0098818"},{"issue":"7","key":"e_1_2_9_30_1","first-page":"2387","article-title":"Chronic lymphocytic leukemic B cells but not normal B cells are rescued from apoptosis by contact with normal bone marrow stromal cells","volume":"91","author":"Lagneaux L","year":"1998","journal-title":"Blood J Am Soc Hematol"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-14-0096"},{"issue":"5","key":"e_1_2_9_32_1","first-page":"1795","article-title":"Protection of CLL B cells by a follicular dendritic cell line is dependent on induction of Mcl\u20101","volume":"100","author":"Pedersen IM","year":"2002","journal-title":"Blood J Am Soc Hematol"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.27646"},{"issue":"8","key":"e_1_2_9_34_1","first-page":"2655","article-title":"Blood\u2010derived nurse\u2010like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell\u2013derived factor\u20101","volume":"96","author":"Burger JA","year":"2000","journal-title":"Blood J Am Soc Hematol"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcmd.2012.12.003"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.13660"},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2014.991731"},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-08-4173"},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00527"},{"key":"e_1_2_9_40_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0175712"},{"issue":"15","key":"e_1_2_9_41_1","first-page":"4497","article-title":"The circulating dendritic cell compartment in patients with chronic lymphocytic leukemia is severely defective and unable to stimulate an effective T\u2010cell response","volume":"63","author":"Orsini E","year":"2003","journal-title":"Cancer Res"},{"key":"e_1_2_9_42_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.10093"},{"key":"e_1_2_9_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2019.02.006"},{"key":"e_1_2_9_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2018.03.018"},{"key":"e_1_2_9_45_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01310"},{"key":"e_1_2_9_46_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12092614"},{"issue":"5","key":"e_1_2_9_47_1","first-page":"666","article-title":"MDSCs: the final frontier of the microenvironment in CLL?","volume":"124","author":"Zirlik K","year":"2014","journal-title":"Blood J Am Soc Hematol"},{"key":"e_1_2_9_48_1","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2014.2808"},{"issue":"5","key":"e_1_2_9_49_1","first-page":"750","article-title":"CLL\u2010cells induce IDOhi CD14+ HLA\u2010DRlo myeloid\u2010derived suppressor cells that inhibit T\u2010cell responses and promote TRegs","volume":"124","author":"Jitschin R","year":"2014","journal-title":"Blood J Am Soc Hematol"},{"key":"e_1_2_9_50_1","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aah5509"},{"key":"e_1_2_9_51_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2015.305"},{"key":"e_1_2_9_52_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00783"},{"key":"e_1_2_9_53_1","doi-asserted-by":"publisher","DOI":"10.3390\/cells9030561"},{"key":"e_1_2_9_54_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00167"},{"key":"e_1_2_9_55_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22136665"},{"key":"e_1_2_9_56_1","doi-asserted-by":"publisher","DOI":"10.1159\/000497208"},{"issue":"6","key":"e_1_2_9_57_1","article-title":"Natural killer cell hypo\u2010responsiveness in chronic lymphocytic leukemia can be circumvented in vitro by adequate activating signaling","volume":"3","author":"Hofland T","year":"2019","journal-title":"Hema"},{"key":"e_1_2_9_58_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14235787"},{"key":"e_1_2_9_59_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.24832"},{"key":"e_1_2_9_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2018.10.014"},{"issue":"10","key":"e_1_2_9_61_1","article-title":"Therapeutic CD94\/NKG2A blockade improves natural killer cell dysfunction in chronic lymphocytic leukemia","volume":"5","author":"McWilliams EM","year":"2016","journal-title":"Onco Targets Ther"},{"issue":"10","key":"e_1_2_9_62_1","article-title":"Ig\u2010like transcript 2 (ILT2) suppresses T cell function in chronic lymphocytic leukemia","volume":"6","author":"Villa\u2010\u00c1lvarez M","year":"2017","journal-title":"Onco Targets Ther"},{"key":"e_1_2_9_63_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13092112"},{"key":"e_1_2_9_64_1","doi-asserted-by":"publisher","DOI":"10.4103\/jcrt.jcrt_52_21"},{"key":"e_1_2_9_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2020.107662"},{"issue":"1","key":"e_1_2_9_66_1","first-page":"1","article-title":"The role of neutrophil death in chronic inflammation and cancer","volume":"6","author":"Brostjan C","year":"2020","journal-title":"Cell Death Dis"},{"key":"e_1_2_9_67_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40164-023-00452-9"},{"key":"e_1_2_9_68_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-016-1921-7"},{"key":"e_1_2_9_69_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-15-3486"},{"key":"e_1_2_9_70_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2012.072835"},{"issue":"26","key":"e_1_2_9_71_1","first-page":"3440","article-title":"Invariant NKT cells contribute to chronic lymphocytic leukemia surveillance and prognosis","volume":"129","author":"Gorini F","year":"2017","journal-title":"Blood J Am Soc Hematol"},{"key":"e_1_2_9_72_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2005.12.013"},{"key":"e_1_2_9_73_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13071502"},{"issue":"21","key":"e_1_2_9_74_1","first-page":"2260","article-title":"Improving CLL V\u03b39V\u03b42\u2010T\u2013cell fitness for cellular therapy by ex vivo activation and ibrutinib","volume":"132","author":"Weerdt I","year":"2018","journal-title":"Blood J Am Soc Hematol"},{"key":"e_1_2_9_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2012.12.003"},{"issue":"4","key":"e_1_2_9_76_1","first-page":"257","article-title":"CD4+ T cells are exhausted and show functional defects in chronic lymphocytic leukemia","volume":"14","author":"Allahmoradi E","year":"2017","journal-title":"Iran J Immunol"},{"key":"e_1_2_9_77_1","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.12880"},{"key":"e_1_2_9_78_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2010.503820"},{"key":"e_1_2_9_79_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-11-2630"},{"issue":"7","key":"e_1_2_9_80_1","first-page":"2427","article-title":"Chronic lymphocytic leukemia T cells show impaired immunological synapse formation that can be reversed with an immunomodulating drug","volume":"118","author":"Ramsay AG","year":"2008","journal-title":"J Clin Invest"},{"key":"e_1_2_9_81_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2016.02.084"},{"key":"e_1_2_9_82_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2013.07.011"},{"key":"e_1_2_9_83_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-0873-2"},{"key":"e_1_2_9_84_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1401350"},{"key":"e_1_2_9_85_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2022008985"},{"key":"e_1_2_9_86_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13277-012-0628-4"},{"key":"e_1_2_9_87_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2011.047316"},{"key":"e_1_2_9_88_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0078091"},{"issue":"9","key":"e_1_2_9_89_1","first-page":"1612","article-title":"T cells from CLL patients exhibit features of T\u2010cell exhaustion but retain capacity for cytokine production","volume":"121","author":"Riches JC","year":"2013","journal-title":"Blood J Am Soc Hematol"},{"issue":"7","key":"e_1_2_9_90_1","first-page":"1412","article-title":"Multiple inhibitory ligands induce impaired T\u2010cell immunologic synapse function in chronic lymphocytic leukemia that can be blocked with lenalidomide: establishing a reversible immune evasion mechanism in human cancer","volume":"120","author":"Ramsay AG","year":"2012","journal-title":"Blood J Am Soc Hematol"},{"issue":"8","key":"e_1_2_9_91_1","first-page":"2269","article-title":"Upregulation of Galectin\u20109 and PD\u2010L1 immune checkpoints molecules in patients with chronic lymphocytic leukemia","volume":"18","author":"Taghiloo S","year":"2017","journal-title":"Asian Pac J Cancer Prev"},{"key":"e_1_2_9_92_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11864-023-01129-5"},{"issue":"2","key":"e_1_2_9_93_1","first-page":"178","article-title":"The effects of PI3K\/Akt\/mTOR signaling pathway inhibitors on the expression of immune checkpoint ligands in acute myeloid leukemia cell line","volume":"21","author":"Taghiloo S","year":"2022","journal-title":"Iran J Allergy Asthma Immunol"},{"key":"e_1_2_9_94_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13277-015-4217-1"},{"issue":"2","key":"e_1_2_9_95_1","first-page":"203","article-title":"PD\u2010L1 checkpoint blockade prevents immune dysfunction and leukemia development in a mouse model of chronic lymphocytic leukemia","volume":"126","author":"McClanahan F","year":"2015","journal-title":"Blood J Am Soc Hematol"},{"issue":"1","key":"e_1_2_9_96_1","first-page":"52","article-title":"Regulatory T\u2010cells in chronic lymphocytic leukemia: actor or innocent bystander?","volume":"3","author":"D'Arena G","year":"2013","journal-title":"Am J Blood Res"},{"key":"e_1_2_9_97_1","doi-asserted-by":"publisher","DOI":"10.3109\/07357907.2012.756110"},{"key":"e_1_2_9_98_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2017.07.004"},{"key":"e_1_2_9_99_1","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2011.164"},{"key":"e_1_2_9_100_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-018-1545-0"},{"key":"e_1_2_9_101_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.16565"},{"key":"e_1_2_9_102_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-018-0344-1"},{"key":"e_1_2_9_103_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15146"},{"key":"e_1_2_9_104_1","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-8-111"},{"key":"e_1_2_9_105_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12020282"},{"issue":"3","key":"e_1_2_9_106_1","article-title":"The regulatory capacity of B cells directs the aggressiveness of CLL","volume":"8","author":"Mohr A","year":"2019","journal-title":"Onco Targets Ther"},{"key":"e_1_2_9_107_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2012.165"},{"key":"e_1_2_9_108_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41417-023-00602-5"},{"key":"e_1_2_9_109_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2015.174"},{"key":"e_1_2_9_110_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1001307"},{"key":"e_1_2_9_111_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2011.11.018"},{"issue":"5","key":"e_1_2_9_112_1","article-title":"Regulatory B lymphocyte functions should be considered in chronic lymphocytic leukemia","volume":"5","author":"Mohr A","year":"2016","journal-title":"Onco Targets Ther"}],"container-title":["European Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ejh.14224","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T12:05:21Z","timestamp":1717416321000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ejh.14224"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,2]]},"references-count":111,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["10.1111\/ejh.14224"],"URL":"https:\/\/doi.org\/10.1111\/ejh.14224","archive":["Portico"],"relation":{},"ISSN":["0902-4441","1600-0609"],"issn-type":[{"value":"0902-4441","type":"print"},{"value":"1600-0609","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,2]]},"assertion":[{"value":"2024-02-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-18","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-05-02","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}